Oncology Today with Dr Neil Love artwork

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Oncology Today with Dr Neil Love

English - May 06, 2024 12:00 - 1 hour - 54 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Next Episode: Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayHER2PanTumor23/3GU).

Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.